These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 18523093)

  • 1. Bimatoprost, the prodrug of a prostaglandin analogue.
    Camras CB; Sharif NA; Wax MB; Stjernschantz J
    Br J Ophthalmol; 2008 Jun; 92(6):862-3; author reply 863-4. PubMed ID: 18523093
    [No Abstract]   [Full Text] [Related]  

  • 2. Update on the mechanism of action of bimatoprost: a review and discussion of new evidence.
    Krauss AH; Woodward DF
    Surv Ophthalmol; 2004 Mar; 49 Suppl 1():S5-11. PubMed ID: 15016556
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bimatoprost: establishing its role in glaucoma management.
    Katz LJ
    Surv Ophthalmol; 2004 Mar; 49 Suppl 1():S1-4. PubMed ID: 15016555
    [No Abstract]   [Full Text] [Related]  

  • 4. Bimatoprost-induced calcium signaling in human T-cells does not involve prostanoid FP or TP receptors.
    Chen J; Lu RT; Lai R; Dinh T; Paul D; Venadas S; Wheeler LA
    Curr Eye Res; 2009 Mar; 34(3):184-95. PubMed ID: 19274525
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Twenty-four-hour intraocular pressure and blood pressure levels with bimatoprost versus latanoprost in patients with normal-tension glaucoma.
    Quaranta L; Pizzolante T; Riva I; Haidich AB; Konstas AG; Stewart WC
    Br J Ophthalmol; 2008 Sep; 92(9):1227-31. PubMed ID: 18586898
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comparison of long-term intraocular pressure fluctuation in patients treated with bimatoprost or latanoprost.
    Simmons ST; Bernstein P; Hollander DA
    Am J Ophthalmol; 2008 Sep; 146(3):473-7. PubMed ID: 18561893
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of oxidative stress in trabecular meshwork cells are reduced by prostaglandin analogues.
    Yu AL; Fuchshofer R; Kampik A; Welge-Lüssen U
    Invest Ophthalmol Vis Sci; 2008 Nov; 49(11):4872-80. PubMed ID: 18971427
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Flare-up rates with bimatoprost therapy in uveitic glaucoma.
    Fortuna E; Cervantes-Castañeda RA; Bhat P; Doctor P; Foster CS
    Am J Ophthalmol; 2008 Dec; 146(6):876-82. PubMed ID: 19027422
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A randomised crossover study comparing bimatoprost and latanoprost in subjects with primary angle closure glaucoma.
    How AC; Kumar RS; Chen YM; Su DH; Gao H; Oen FT; Ho CL; Seah SK; Aung T
    Br J Ophthalmol; 2009 Jun; 93(6):782-6. PubMed ID: 19336424
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bimatoprost and prostaglandin F(2 alpha) selectively stimulate intracellular calcium signaling in different cat iris sphincter cells.
    Spada CS; Krauss AH; Woodward DF; Chen J; Protzman CE; Nieves AL; Wheeler LA; Scott DF; Sachs G
    Exp Eye Res; 2005 Jan; 80(1):135-45. PubMed ID: 15652534
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and tolerability of prostaglandin analogs: a meta-analysis of randomized controlled clinical trials.
    Aptel F; Cucherat M; Denis P
    J Glaucoma; 2008 Dec; 17(8):667-73. PubMed ID: 19092464
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prostaglandin analogues in angle closure glaucoma.
    Gupta P; Mahesh BS; Gupta HL
    Indian J Ophthalmol; 2011; 59(5):411-2. PubMed ID: 21836364
    [No Abstract]   [Full Text] [Related]  

  • 13. Long-term efficacy and safety of bimatoprost for intraocular pressure lowering in glaucoma and ocular hypertension: year 4.
    Williams RD; Cohen JS; Gross RL; Liu CC; Safyan E; Batoosingh AL;
    Br J Ophthalmol; 2008 Oct; 92(10):1387-92. PubMed ID: 18621791
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhancing the growth of natural eyelashes: the mechanism of bimatoprost-induced eyelash growth.
    Cohen JL
    Dermatol Surg; 2010 Sep; 36(9):1361-71. PubMed ID: 20384750
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The biodisposition and hypertrichotic effects of bimatoprost in mouse skin.
    Woodward DF; Tang ES; Attar M; Wang JW
    Exp Dermatol; 2013 Feb; 22(2):145-8. PubMed ID: 23278986
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and safety of bimatoprost as replacement for latanoprost in patients with glaucoma or ocular hypertension: a uniocular switch study.
    Casson RJ; Liu L; Graham SL; Morgan WH; Grigg JR; Galanopoulos A; Crawford A; House PH
    J Glaucoma; 2009; 18(8):582-8. PubMed ID: 19826386
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Commercially available prostaglandin analogs for the reduction of intraocular pressure: similarities and differences.
    Bean GW; Camras CB
    Surv Ophthalmol; 2008 Nov; 53 Suppl1():S69-84. PubMed ID: 19038626
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Instilled bimatoprost ophthalmic solution in patients with eyelash alopecia areata.
    Ochoa BE; Sah D; Wang G; Stamper R; Price VH
    J Am Acad Dermatol; 2009 Sep; 61(3):530-2. PubMed ID: 19700021
    [No Abstract]   [Full Text] [Related]  

  • 19. Novel treatment of female-pattern androgenetic alopecia with injected bimatoprost 0.03% solution.
    Emer JJ; Stevenson ML; Markowitz O
    J Drugs Dermatol; 2011 Jul; 10(7):795-8. PubMed ID: 21720663
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lack of efficacy of topical latanoprost and bimatoprost ophthalmic solutions in promoting eyelash growth in patients with alopecia areata.
    Roseborough I; Lee H; Chwalek J; Stamper RL; Price VH
    J Am Acad Dermatol; 2009 Apr; 60(4):705-6. PubMed ID: 19293023
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.